Prostate cancer is a malignant tumor that develops in the prostate gland, a part of the male reproductive system.

Divya Gupta, MD, assistant professor at Feinberg School of Medicine at Northwestern University, discussed the potential of using circulating tumor DNA and minimal residual disease (MRD) assays for ...

November is Lung Cancer Awareness Month — coinciding with the start of open enrollment for Affordable Care Act (ACA) ...

locally advanced, or metastatic non-small cell lung cancer (NSCLC). While the trial did not meet its primary endpoint of ...

US-based immuno-oncology company Aulos Bioscience has announced the first patients have been dosed as part of a trial ...

Accompanying these findings is a call for refined treatment strategies that have potential to better outcomes among patients ...

The combination of HBI-8000 and nivolumab induced a response in nearly two-thirds of patients with advanced melanoma and no ...

In recent decades, immunotherapy has transformed cancer treatment, offering effective options for diseases once considered ...

Bevacizumab biosimilars have the potential to expand access and reduce costs without compromising patient outcomes in ...

Dr. David Cooke with the UC Davis Comprehensive Cancer Center told ABC10 those who are at the highest risk of lung cancer are ...

"While I got my boxing gloves on, let me be one of the first ones to do it. I said I really don't have anything to lose at ...

Treatment for lung cancer depends on the size and location of the nodule. If the nodule is easily accessible, the patient ...